Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

1.42
Delayed Data
As of Apr 29
 -0.04 / -2.74%
Today’s Change
1.08
Today|||52-Week Range
4.11
-13.41%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Traber Peter G
President & Chief Executive Officer
Buy6/01/20154,000$2.53$10.1K-47.21%
Freeman Kevin D
Director
Buy6/01/20152,083$2.70$5.6K-47.21%
Traber Peter G
President & Chief Executive Officer
Buy8/12/20152,000$2.00$4.0K-40.34%
Greenberg Arthur R
Director
Buy1/05/20161,666$1.72$2.9K-19.32%
Amelio Gilbert Frank
Director
Sale11/30/2015100$2.10$210.00-29.00%
Rubin Marc
Director
Gift5/21/20152,768$0.00$0.00-47.60%